Jiglu: Farmtalking: Discussion: Bommeli Diagnostics launches New CHEKIT-APP-AppIV Test

Originally from: lina

Bommeli Diagnostics launches New CHEKIT-APP-AppIV Test
11 Apr 2003

Liebefeld-Bern, Switzerland -March 15, 2003- Bommeli
Diagnostics, the diagnostic unit within Akzo Nobels
veterinary business Intervet International bv today
announced the launch of its new and improved CHEKIT
-APP-ApxIV antibody test, a labaratory assay for the
detection of Actinobacillus pleuropneumoniae (APP)
specific antibodies in swine serum and plasma samples.
The Bommeli Diagnostics enzyme linked immuno-sorbent
assay (ELISA) is the APP antibody test based on the
recombinant and patent protected ApxIV toxin. The new
test version has been improved as far as diagnostic
specificity and sensitivity is concerned. It is the
only assay specifically detecting APP antibodies and
allowing differentiation between infected animals and
not infected animals vaccinated with the proven
Porcilis® APP vaccine. Both tools represent a unique
approach to control pleuropneumonia, one of the most
devastating respiratory diseases in the swine
industry.
Bommeli Diagnostics (www. Bommeli.com) is one of the
leading companies in the centralized veterinary
diagnostic market offering a complete product range
for the control of the most important disease in
livestock. Bommeli Diagnostics and Intervet together
are offering complete solutions for the control of all
major diseases.

Notes tor the editor

Akzo Nobel, based in the Netherlands, serves customers
throughout the world with healthcare products,
coatings and chemicals. Consolidated sales for 2002
totaled EUR 14 billion. The Company currently employs
over 68,000 people in more than 80 countries.
Financial results for the first quarter will be
published on April 16, 2003.

Intervet, a business unit of Akzo Nobel, headquartered
in Boxmeer, the Netherlands, with sales in 2002 of EUR
1 ,081 million, is focused on the research and
development, manufacturing and marketing of veterinary
products. Products include vaccines for the prevention
of infectious diseases, anti-infectives,
antiparasitics, feed additives, products for fertility
management and veterinary diagnostics. All of these
products are intended for use in a variety of animal
species, including poultry, pigs, cattle, sheep,
goats, horses, fish and companion animals. Intervet
operates globally through its own marketing
organizations. The company currently employs around
5,000 people.